Telestroke Imaging: A Review.
The use of telecommunications technology to provide the healthcare services, telemedicine, has been in use since the 1860s. The use of technology has ranged from providing medical care to far-off places during wartimes to monitoring physiological measurements of astronauts in space. Since the 1990s, reports have been published on diagnoses of neurological diseases with the use of video links. Studies confirm that the neurological examinations, including the National Institutes of Health Stroke Scale, performed during teleneurology are dependable. The transfer of stroke patients in rural hospitals to bigger medical centers delays treatment while there exists current and projected shortage of neurologists. Telestroke provides the solution. Patients suspected of acute stroke need a noncontrast computerized tomography (CT) scan for tissue plasminogen activator administration. Vascular imaging such as CT angiography, magnetic resonance angiography, and digital subtraction angiography can help show large-vessel occlusion or critical stenosis responsive to endovascular therapy. A standard protocol can be followed to decide a vascular modality of choice, considering advantages and disadvantages of each imaging modality. Telestroke solves the problems of distance and of shortage of neurologists. Neuroimaging plays a vital role in the delivery of telestroke, and the telestroke doctor should be comfortable with making a decision on selecting an appropriate vascular imaging modality.
Stroke Institute, Department of Neurology, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA.
Fahad J
FJ
Laghari
Stroke Institute, Department of Neurology, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA.
Maxim D
MD
Hammer
D005343:Fibrinolytic Agents / Q000008:administration & dosage; D049672:History, 19th Century; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D009462:Neurology / Q000379:methods; D020521:Stroke / Q000000981:diagnostic imaging* / Q000188:drug therapy; D017216:Telemedicine / Q000266:history / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D049269:Videoconferencing; D000078329:Workforce
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator
Telemedicine; neuroimaging; teleneurology; telestroke